eConsult Health, a provider of digital triage service platform for primary and emergency care providers, raised £5 million (~$6.5 million) from Gresham House Ventures.
Gresham House Ventures’ investment was led by Investment Director – Henry Alty, who focuses on process automation technology, alongside Maya Ward and James Hendry.
According to the company, the digital triage platform includes eConsult – an online consultation platform for primary care providers. eTriage – a platform for NHS Emergency Departments and Urgent Treatment Centres designed to automatically check-in and prioritize patients upon arrival. eTriage also streamlines the process, identifying sick patients earlier, reducing the waiting time and time to treatment within the department, and delivering improved patient journeys. eSpecialist – a solution for outpatient care to ensure clinicians have the right information to diagnose, manage, and treat patients at the earliest point, according to the company.
“By expanding its services to cover secondary as well as primary care, eConsult Health has the potential to go even further and completely revolutionize healthcare provision in the UK, improving outcomes while at the same time driving effectiveness. We are very excited to work alongside an extremely knowledgeable management team and further improve their current platform,” said Henry Alty, Investment Director at Gresham House Ventures.
With new funds, eConsult Health plans to roll out its urgent and emergency care triage solution and outpatient referral software.
Dr. Murray Ellender, CEO of eConsult Health, commented: “This funding will help us keep pace with the product development we need to support cutting edge health technology across both primary and secondary care.”
Telemedicine companies in the first nine months of 2020 raised $3.3 billion in funding. Recently, 98point6, a provider of on-demand text-based primary care service through a mobile app, raised $118 million in a Series E funding round. The company has raised $247 million to date, including a $43 million Series D funding round in April 2020.
